Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ºñó¹æ ÀǾàǰ > ¹Ì±¹ÀÇ ¼Ò¾Æ°ú OTC¾à°ú ÇコÄɾî Á¦Ç° ½ÃÀå
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4544)
°¨¿°Áúȯ (322)
°ñÁúȯ Ä¡·á (48)
´ç´¢º´ (164)
¹é½Å (170)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (49)
ºñó¹æ ÀǾàǰ (149)
¼öÀÇÇÐ (18)
½Å°æÁúȯ (179)
½Å¾à°³¹ß (1331)
¾ÏÄ¡·á (856)
¾à¹°Àü´Þ (179)
ÀǾàǰ ±ÔÁ¦È¯°æ (106)
Á¤½ÅÁúȯ (88)
Á¦³×¸¯ ÀǾàǰ (117)
Á¦¾àȸ»çºÐ¼® (489)
󹿾à (128)
½ÃÀ庸°í¼­

¹Ì±¹ÀÇ ¼Ò¾Æ°ú OTC¾à°ú ÇコÄɾî Á¦Ç° ½ÃÀå

The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

¸®¼­Ä¡»ç Kalorama Information
¹ßÇàÀÏ 2006³â 03¿ù »óǰÄÚµå 36927
ÆäÀÌÁö Á¤º¸ 260 pages
°¡°Ý
US $ 3,000 £Ü 3,380,700 PDF by E-mail (Single User License)
US $ 3,000 £Ü 3,380,700 Hard Copy
US $ 3,300 £Ü 3,718,700 PDF by E-mail (Single User License) & Hard Copy
US $ 6,000 £Ü 6,761,400 PDF by E-mail (Global Site License)


Kalorama Information ¿¡¼­ 2006³â 03¿ù ¿¡ ¹ßÇàÇÑ ¡¸¹Ì±¹ÀÇ ¼Ò¾Æ°ú OTC¾à°ú ÇコÄɾî Á¦Ç° ½ÃÀ塹 º¸°í¼­´Â 260 pages·Î ±¸¼ºµÇ¾î, US $3,000 ºÎÅÍ ±¸¸Å °¡´ÉÇÕ´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ·á½ÃÀåÀº 2000³â ¼Ò¸ÅÆÇ¸Å¾× 7¾ï 8,660¸¸ ´Þ·¯¿¡¼­ 2004³â¿¡ 8¾ï4,310¸¸ ´Þ·¯°¡ µÇ´Â µî, 2000³â ÀÌÈÄ ¼øÁ¶·Ó°Ô È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Á¦¾à, ¹ÙÀÌ¿À, ÀÇ·á±â±â¸¦ ½ÃÀÛÀ¸·Î »ý¸í°úÇÐ ½ÃÀå Á¶»ç¸¦ Àü¹®À¸·Î ÇÏ´Â ¹Ì±¹ÀÇ ¸®¼­Ä¡ ȸ»ç Kalorama Information (º»»ç: ´º¿åÁÖ)¿¡¼­´Â ¹Ì±¹ÀÇ ¼Ò¾Æ°ú OTC¾à°ú ÇコÄɾî Á¦Ç°¿¡ ´ëÇØ Á¤¸®ÇÑ º¸°í¼­ ¡°The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products¡±¸¦ ¹ßÇàÇß½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­´Â ¹Ì±¹ÀÇ ¼Ò¾Æ°ú OTC¾à°ú ½ÃÀ嵿Çâ, ½ÃÀå Âü°¡±â¾÷ °³¿ä¿Í ÁÖ¿ä ºê·£µå, ½ÃÀå¿¡ ¿µÇâÀ» ÁÖ´Â °úÁ¦³ª ±ÔÁ¦ µ¿Çâµî¿¡ ´ëÇØ ´ë·« ¾Æ·¡¿Í °°Àº ±¸¼ºÀ¸·Î ÀüÇØµå¸³´Ï´Ù.

    Á¦1Àå ÁÖ¿ä ¿ä¾à
    Á¦2Àå ½ÃÀå
    • ½ÃÀåÀÇ Á¤ÀÇ
    • Á¦Ç° °³¿ä
      • ÁøÅëÁ¦
      • º¹ÇÕÁ¦Á¦
      • ±¹¼Ò¿ë¾àÁ¦
      • °¨±â, ±âħ, ¾Ë·¹¸£±â, °í¸§
      • OTC ¼Ò¾Æ¿ë °¨±â, ±âħ, ¾Ë·¹¸£±â, °í¸§ÀÇ ºÐ·ù
      • ±âŸ Ä¡·á
      • ÀÀ±Þóġ
    • ±ÔÁ¦ ȯ°æ
      • ºê·£µå¿Í Á¦³×¸¯ ÀǾàǰ
      • ÄÚ½ºÆ® ÆÑÅÍ
    • ¼Ò¾Æ°ú¾à
      • ¼Ò¾Æ°ú¾à ½ÃÇèÀÇ °úÁ¦
      • ¼Ò¾Æ°ú ±ÔÁ¦ÀÇ ¿ª»ç
      • ½ºÆù¼­
      • Pediatric Research Equity Act
      • À¯¾Æ¿ë ¾àÁ¦ÀÇ ¶óº§¸µ
      • ¶óº§¸µ ¹æÄ§
      • ¼Ò¾Æ¿ë ¶óº§¸µ
      • 2005³â ¶óº§¸µÀÇ º¯µ¿
      • ¼ºÀÎ¿ë ¿ÀÇÁ¶óº§ÀÇ ¾î¸°ÀÌ¿¡ ´ëÇÑ »ç¿ë
      • ¼Ò¾ÆÀα¸¿ë Ä¡Çè
    • ½ÃÀå µ¥ÀÌÅÍ
    • ½ÃÀå ¼¼±×¸ÕÆ®
      • °¨±â, °í¸§, ¾Ë·¹¸£±â Ä¡·á
      • ÁøÅëÁ¦
      • ±âħ¾àÀÌ ½ÃÀåÀ» ¸®µåÇÑ´Ù.
      • ÀÀ±Þóġ
      • ±âŸ ¼Ò¾Æ°ú¾à
    • ÁÖ¿ä µ¿Çâ°ú ¼ºÀå ¿äÀÎ
      • ÀÇ»çÀÇ ¹æ¹® µ¿Çâ
      • ¼Ò¾Æ°úÀÇ»ç ¹æ¹®
      • ÀÇ»çÀÇ ¹æ¹®Àº ¼èÅðÇϰí ÀÖ´Ù.
      • Æä´Ï½Ç¸°:ÀÇ»ç ¹æ¹®Áß¿¡ °¡Àå ¸¹ÀÌ Åõ¾à
      • ¾à¹°Àü´Þ°ú Á¦Á¦ µ¿Çâ
      • ½Å¾à ½ÂÀÎ µ¿Çâ
      • ÇコÄÉ¾î ºñ¿ë°ú º¸Çè µ¿Çâ
      • Ãâ»ý·ü
      • ¼¿ÇÁ¸ÞµðÄÉÀ̼Ç
      • ¼Ò¾Æ°ú °Ç°­ µ¿Çâ°ú º´
      • ¾î¸°ÀÌ ºñ¸¸ÀÇ Áõ°¡
      • ¹éÀÏÇØ
      • Á¦³×¸¯ ÀǾàǰ
    • ½ÃÀå ¿¹Ãø
    Á¦3Àå ¸¶ÄÉÅÍ
    • OTC ¼Ò¾Æ¿ë ±âħ/°¨±â/¾Ë·¹¸£±â/°í¸§
    • OTC ¼Ò¾Æ°ú ±¸±Þ Ä¡·á¿ë Á¦Ç°
    • OTC ¼Ò¾Æ ÁøÅëÁ¦
    • ±âŸ ¾àÁ¦
    Á¦4Àå ¼ÒºñÀÚ
    • ¼­·Ð
    • OTC ¾î¸°ÀÌ¿ë ±âħ.°¨±â¾à
    • ¾î¸°ÀÌ¿ë ÇØ¿­/ÁøÅëÁ¦
    • ±¸±ÞÁ¤/Ç×»ý ¹°Áú
    • Simmons Kids Survey
    Á¦5Àå ¸¶ÄÉÆÃ µ¿Çâ
    • ±¤°í¿Í ÇÁ·Î¸ð¼Ç
      • Johnson & JohnsonÀÇ ±¤°í ¼±Àüºñ
      • Tylenol Scholarship 2005
      • °¡°Ý ÀÎÇÏ
      • ¸¸È­ ij¸¯ÅÍ ¶óÀ̼¾½Ì
    • ¾àÁ¦ ÆÇ¸Å¿Í ¼Ò¸Å °³¿ä
      • ¾à±¹ üÀÎ
      • e-ÆÄ¸Ó½Ã
    • ¼Ò¸Å µ¿Çâ
    • ½ÅÁ¦Ç° µµÀÔ
    • Çõ½Å
    Á¦6Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Procter and Gamble
    • Johnson & Johnson
    • Novartis AG
    • Pfizer Inc
    • Wyeth
    • Prestige Brands Holding, Inc.
    • ROHTO Pharmaceutical Co.,Ltd
    • 3M Company
    • Beiersdorf AG
    • Bristol-Myers Squibb Company
    • Taro Pharmaceuticals Industries Ltd.
    • Schering-Plough Corporation
    • ºÎ·Ï: ±â¾÷ µð·ºÅ丮
cji
Back to Top